Q3 2019 13F Holders as of 30 Sep 2019
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
49,633,071
-
Total 13F shares
-
33,378,445
-
Share change
-
+1,448,213
-
Total reported value
-
$359,419,047
-
Put/Call ratio
-
140%
-
Price per share
-
$10.77
-
Number of holders
-
134
-
Value change
-
+$12,539,026
-
Number of buys
-
84
-
Number of sells
-
53
Institutional Holders of PUMA BIOTECHNOLOGY, INC. - Common Stock (PBYI) as of Q3 2019
As of 30 Sep 2019 PUMA BIOTECHNOLOGY, INC. - Common Stock (PBYI) had 134 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 33,378,445 shares of stock of the company.
Largest 10 holders included Partner Fund Management, L.P., VANGUARD GROUP INC, STATE STREET CORP, FRED ALGER MANAGEMENT, LLC, Sarissa Capital Management LP, Palo Alto Investors LP, Nuveen Asset Management, LLC, MACQUARIE GROUP LTD, GOLDMAN SACHS GROUP INC, and FEDERATED INVESTORS INC /PA/.
This table shows 134 institutional shareholders of the security as of 30 Sep 2019.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.